0001104659-16-139358.txt : 20160812 0001104659-16-139358.hdr.sgml : 20160812 20160812163054 ACCESSION NUMBER: 0001104659-16-139358 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160811 FILED AS OF DATE: 20160812 DATE AS OF CHANGE: 20160812 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC CENTRAL INDEX KEY: 0001621227 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 101 PARK DRIVE STREET 2: MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RY BUSINESS PHONE: 44 1235 430000 MAIL ADDRESS: STREET 1: 101 PARK DRIVE STREET 2: MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RY FORMER COMPANY: FORMER CONFORMED NAME: Adaptimmune Ltd DATE OF NAME CHANGE: 20141001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sigal Charles Elliott CENTRAL INDEX KEY: 0001661908 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37368 FILM NUMBER: 161828630 MAIL ADDRESS: STREET 1: 32 BREARLY ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 a4.xml 4 X0306 4 2016-08-11 0 0001621227 Adaptimmune Therapeutics PLC ADAP 0001661908 Sigal Charles Elliott 32 BREARLY ROAD PRINCETON NJ 08540 1 0 0 0 Option to purchase Ordinary Shares 1.27 2016-08-11 4 A 0 184562 0 A 2017-08-11 2026-08-11 Ordinary Shares 184562 184562 D The exercise price was converted from GBP0.97 based on the closing midpoint exchange rate for the U.S. dollar on the day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount. /s/ Charles Elliott Sigal 2016-08-12